Sunshine Biopharma (SBFM) announced its Board of Directors has formally approved a strategic investment of $5M in Bitcoin (BTC-USD) as a strategic reserve asset. This move aligns with Sunshine Biopharma’s broader strategy to strengthen its financial foundation while advancing its pipeline of generic prescription drugs and proprietary mRNA-based cancer therapies and antiviral drug candidates. The Company’s Bitcoin investment of $5M will be executed over time through a regulated digital asset custodian or, the purchase of an ETF or a proxy stock. The Company plans to increase its holdings of Bitcoin by allocating additional funds as such funds become available in the future.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.